current
pandem
spread
rapidli
worldwid
may
becom
one
largest
pandem
event
modern
histori
control
appear
viru
infect
result
death
mainli
due
dysfunct
failur
lung
multipl
organ
could
attribut
host
immunodysfunct
particularli
hyperinflammatori
type
disord
brief
review
studi
math
model
propos
correl
pathogen
infect
recoveri
probabl
pirp
versu
proinflammatori
antipathogen
speci
piap
level
within
host
unit
maximum
pirp
exhibit
piap
level
equal
around
piap
equilibrium
level
pathogen
elimin
clearanc
onset
base
model
ration
effect
therapeut
strategi
right
stage
time
right
type
agent
immunostimul
immunosuppressor
right
dosag
may
design
implement
expect
effect
achiev
maximum
pirp
reduc
mortal
current
pandem
due
virus
alreadi
spread
around
globe
result
thirti
thousand
human
death
twenti
time
confirm
infect
addit
loss
human
life
social
econom
loss
effect
could
signific
number
earlier
global
pandem
occur
human
histori
attribut
pathogen
infect
though
differ
among
differ
pathogen
induc
infect
certain
similar
among
pathogen
infect
pathogen
mainli
refer
biolog
microorgan
virus
includ
new
viru
bacteria
selfrepl
biolog
host
trigger
initi
host
immun
system
respons
result
product
clonal
expans
antipathogen
speci
ap
includ
seri
proinflammatori
antipathogen
speci
piap
piap
mainli
refer
doubleedg
sword
speci
certain
white
blood
cell
wbc
generatedrel
speci
oxid
radic
speci
antibodi
cytokin
etc
doubleedg
sword
refer
certain
piap
attack
pathogen
also
attack
host
normal
cell
tissu
pathogen
infect
model
could
use
understand
infect
mechan
process
prevent
therapeut
strategi
howev
exist
model
work
mainli
focus
multipl
host
infect
transmitt
statist
time
domain
model
work
provid
insight
pathogen
infect
recoveri
probabl
pirp
antipathogen
speci
ap
particularli
proinflammatori
antipathogen
speci
piap
focu
studi
pathogen
infect
host
may
result
pathogen
uncontrol
growth
host
immun
system
weak
defici
dysregul
includ
immunoparalysi
seriou
immun
defici
syndrom
could
result
sepsi
septic
shock
host
normal
immun
respons
system
illustr
figur
pathogen
infect
time
end
incub
period
typic
trigger
normal
effici
growth
clonal
expans
immun
system
gener
antipathogen
speci
ap
initi
level
ideal
shall
result
pathogen
eliminatedclear
te
pathogen
elimin
ap
te
ap
includ
piap
growth
expect
ceas
remain
equilibrium
level
xe
certain
ap
certain
pathogen
specif
antibodi
expect
remain
equilibrium
level
certain
period
time
pathogen
infect
prevent
inhibit
principl
vaccin
though
antibodi
equilibrium
level
slow
decay
long
period
time
normal
expect
howev
certain
immunodysfunct
disord
particularli
certain
hyperinflammatori
disord
cytokin
releas
syndrom
cr
cytokin
storm
cs
macrophag
activ
syndrom
ma
macrophagecytokin
selfamplifi
loop
mcsal
wb
prolif
disord
certain
piap
grow
control
effici
dampen
host
antiinflammatori
speci
eg
even
te
pathogen
may
elimin
known
number
piap
attack
damag
normal
healthi
cell
result
tissu
death
gangren
multipl
organ
dysfunct
failur
reason
potenti
practic
therapeut
strategi
gaussian
bell
shape
normal
distribut
function
propos
model
pathogen
infect
recoveri
probabl
pirp
surviv
counter
mortal
versu
piap
level
x
shown
figur
exhibit
equat
paramet
proport
pirp
distribut
peak
full
width
half
maximum
fwhm
affect
piap
level
rang
width
around
pirp
maximum
rang
piap
level
significantli
elev
pirp
compar
piap
rang
pirp
remain
rel
low
paramet
repres
coupl
factor
pirp
versu
piap
level
reflect
signific
effect
piap
level
affect
pirp
time
base
model
pirppiap
curv
divid
two
stage
stage
pirp
rise
stage
correspond
pathogenap
evolut
time
period
te
shown
figur
pirp
pathogen
infect
host
start
rise
host
normal
immun
respons
gener
ap
includ
piap
grow
effici
initi
level
zero
pathogen
specif
ap
eventu
approach
maintain
equilibrium
level
xe
blue
solid
line
pathogen
elimin
clear
stage
ii
pirp
descend
stage
piap
level
grow
beyond
equilibrium
level
xe
repres
long
dash
blue
line
repres
immunodysregul
hyperinflammatori
disord
pirp
descend
presum
due
excess
piap
start
damag
normal
healthi
tissu
organ
eventu
pirp
could
descend
low
level
due
heavi
damag
tissu
particularli
lung
tissu
could
result
multipl
organ
failur
base
model
gener
therapeut
strategi
minim
mortal
achiev
andor
sustain
maximum
pirp
via
twostag
protocol
follow
stage
pirp
rise
stage
te
host
normal
immun
respons
pathogen
infect
host
apspiap
grow
effici
toward
equilibrium
satur
level
xe
pathogen
elimin
clear
situat
stage
viral
target
therapi
appear
unnecessari
except
support
therapi
need
follow
situat
host
exhibit
breath
difficulti
dyspnea
low
blood
oxygen
level
due
liquidsmuc
lung
lung
infect
mechan
respir
ventil
andor
oxygen
therapi
may
util
prevent
potenti
oxygen
defici
syndrom
relat
complic
hypoxemia
hypoxia
b
pathogen
growth
control
case
host
certain
immun
defici
syndrom
either
pathogen
inhibitorssuppressor
avail
ap
boostersenhanc
immunostimul
includ
certain
wbc
therapi
antibodyimmunoglobin
therapi
interferon
therapi
well
therapi
util
plasma
antibodi
obtain
convalesc
patient
may
administ
minim
potenti
viral
damag
result
complic
immuno
stimul
must
administ
right
time
stage
te
right
type
apspiap
boostersenhanc
instead
inhibitorssuppressor
right
dosag
ie
apspiap
level
care
monitor
control
equal
close
equilibrium
satur
level
xe
stage
ii
pirp
descend
stage
te
piap
level
excess
growth
control
dysregul
critic
essenti
therapeut
task
post
te
period
stage
ii
shall
promptli
termin
suppress
growth
piap
level
immunosuppress
varieti
antiinflammatori
method
may
test
nearbi
equilibrium
level
xe
pathogen
inhibitorssuppressor
may
necessari
time
pathogen
elimin
case
coupl
host
gener
ap
pathogen
poor
ie
hyperinflamm
cytokin
storm
occur
pathogen
level
still
high
pathogen
suppressorsinhibitor
avail
antiinflammatori
noninflammatori
ap
well
piap
suppressor
may
administ
situat
stage
care
control
dosag
certain
host
immun
system
gener
antiinflammatori
speci
ai
may
grow
order
counter
inflamm
antiinflammatori
respons
could
slow
may
eventu
reduc
host
piap
level
well
equilibrium
level
may
result
host
immunoparalysi
number
therapeut
piap
control
immunomodul
effort
report
recent
year
howev
time
type
dosag
piap
suppressorsantagonist
must
care
monitor
control
appear
yet
done
piap
oversuppress
wrong
stage
could
result
delay
incomplet
pathogen
elimin
well
vulner
host
reinfect
secondari
infect
relat
complic
final
sinc
host
mentalpsycholog
statu
mode
fear
includ
claustrophobia
anxieti
distress
depress
etc
could
trigger
host
catecholamineadrenalin
product
turn
could
boost
apspiap
level
macrophagecytokin
selfamplifi
loop
mcsal
inflamm
may
result
modeinflamm
selfamplifi
loop
misal
psycholog
counsel
host
thu
also
appear
import
improv
host
pirp
precis
fast
conveni
reliabl
protocol
measur
monitor
pathogen
key
doubleedg
sword
piap
level
essenti
valid
model
eventu
util
model
gener
protocol
safe
effect
therapeut
treatment
infect
host
pathogen
key
piap
target
critic
biomark
asap
exampl
case
appear
lack
evid
organ
damag
due
viru
excess
level
presenc
macrophag
neutrophil
inflammatori
cytokin
observ
multipl
damag
organ
autopsi
biopsi
viru
infect
host
though
apspiap
booster
interferon
infalpha
gamma
immunoglobulin
convalesc
plasma
collect
recov
patient
recommend
infect
treatment
base
model
treatment
may
best
use
host
defici
weak
immun
respons
administ
stage
piap
suppress
via
seri
inflamm
antagonist
cytokin
elimin
via
blood
purif
appear
use
control
cr
done
te
stage
ii
piap
level
control
extrem
critic
importantli
level
key
piap
level
particularli
macrophag
neutrophil
appropri
time
interv
need
measur
monitor
precis
close
order
monitor
determin
viru
growth
viru
elimin
onset
time
te
correspond
piap
equilibrium
level
xe
infect
appear
mani
host
antibodi
lgg
equilibrium
level
xe
four
time
initi
level
approach
control
dysregul
interferon
infi
product
infect
appear
potenti
use
valid
util
model
interferon
infi
level
control
done
te
level
suppress
well
xe
anoth
exampl
twostag
model
might
applic
applic
certain
antioxid
assum
vitaminsc
function
antioxid
radic
scaveng
appear
need
stage
ii
pathogen
supress
oxid
radic
actual
need
stage
final
multipl
host
unit
may
util
obtain
averag
valu
six
paramet
model
te
xe
particular
host
group
averag
valu
may
use
therapeut
treatment
individu
host
similar
member
group
summari
bell
shape
normal
distribut
function
propos
model
pathogen
infect
recoveri
probabl
pirp
versu
proinflammatori
antipathogen
speci
piap
level
microorgan
base
pathogen
infect
host
base
model
therapeut
strategi
base
two
stage
first
stage
treatment
may
necessari
host
normal
immun
respons
pirp
expect
grow
remain
maximum
due
apspiap
grow
remain
equilibrium
level
xe
certain
period
except
support
treatment
need
oxygen
defici
syndrom
host
weak
defici
antipathogen
immun
respons
may
need
either
pathogen
suppressor
immunostimul
howev
time
type
dosag
pathogen
suppressor
immunostimul
critic
second
pirp
descend
stage
ii
due
piap
excess
abnorm
growth
level
essenti
control
piap
around
equilibrium
level
xe
via
immunosuppressor
inflamm
antagonist
pathogen
level
still
high
stage
ii
antiinflammatori
noninflammatori
immunostimul
desir
time
type
dosag
therapeut
treatment
extrem
critic
depend
pirp
stage
pathogenpiap
level
precis
time
monitor
control
pathogen
piap
level
essenti
order
fulli
character
util
model
increas
surviv
reduc
mortal
could
potenti
outcom
relat
model
fulli
develop
well
character
implement
care
design
control
clinic
trial
instanc
current
infect
immunomodul
via
time
precis
monitor
level
control
key
biomark
includ
viru
macrophag
andor
neutrophil
oxid
radic
speci
etc
appear
essenti
reduc
mortal
author
wish
thank
child
allergi
specialist
dr
kelli
mapl
help
discuss
cytokineschemokin
relat
hyperinflamm
pathogen
infect
food
allergi
thank
colleagu
biochemistri
professordr
joseph
hall
help
discuss
pathogenantipathogen
author
also
wish
acknowledg
brother
mr
honggang
sun
insight
discuss
happi
medium
doctrin
confuciu
philosophi
establish
taught
china
thousand
year
author
particularli
wish
acknowledg
thank
friend
dr
donald
sole
md
famili
medic
practition
overwhelm
recent
week
tri
take
care
mani
patient
includ
patient
also
gracious
spent
time
review
discuss
author
articl
author
wish
express
deep
appreci
admir
medic
staff
medic
doctor
nurs
etc
worldwid
risk
live
tri
save
live
other
current
global
human
battl
